260 related articles for article (PubMed ID: 24854541)
1. Immune-modulating effects of alpha-1 antitrypsin.
Ehlers MR
Biol Chem; 2014 Oct; 395(10):1187-93. PubMed ID: 24854541
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
3. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H
Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of alpha-1 antitrypsin in human disease.
Kim M; Cai Q; Oh Y
Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):131-135. PubMed ID: 30286568
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-antitrypsin in cell and organ transplantation.
Berger M; Liu M; Uknis ME; Koulmanda M
Am J Transplant; 2018 Jul; 18(7):1589-1595. PubMed ID: 29607607
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.
Zhu H; He J; Liu J; Zhang X; Yang F; Liu P; Wang S
Exp Biol Med (Maywood); 2018 Jan; 243(1):87-95. PubMed ID: 29096562
[TBL] [Abstract][Full Text] [Related]
7. Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.
Guttman O; Baranovski BM; Schuster R; Kaner Z; Freixo-Lima GS; Bahar N; Kalay N; Mizrahi MI; Brami I; Ochayon DE; Lewis EC
Clin Exp Immunol; 2015 Feb; 179(2):161-72. PubMed ID: 25351931
[TBL] [Abstract][Full Text] [Related]
8. Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin.
Tumpara S; Gründing AR; Sivaraman K; Wrenger S; Olejnicka B; Welte T; Wurm MJ; Pino P; Kiseljak D; Wurm FM; Janciauskiene S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360706
[TBL] [Abstract][Full Text] [Related]
9. Expanding the clinical indications for α(1)-antitrypsin therapy.
Lewis EC
Mol Med; 2012 Sep; 18(1):957-70. PubMed ID: 22634722
[TBL] [Abstract][Full Text] [Related]
10. T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin.
Baranovski BM; Freixo-Lima GS; Lewis EC; Rider P
Biomed Res Int; 2015; 2015():184574. PubMed ID: 26583093
[TBL] [Abstract][Full Text] [Related]
11. α 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells.
Kalis M; Kumar R; Janciauskiene S; Salehi A; Cilio CM
Islets; 2010; 2(3):185-9. PubMed ID: 21099312
[TBL] [Abstract][Full Text] [Related]
12. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
Bergin DA; Hurley K; McElvaney NG; Reeves EP
Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104
[TBL] [Abstract][Full Text] [Related]
14. α-1-antitrypsin inhibits acute liver failure in mice.
Jedicke N; Struever N; Aggrawal N; Welte T; Manns MP; Malek NP; Zender L; Janciauskiene S; Wuestefeld T
Hepatology; 2014 Jun; 59(6):2299-308. PubMed ID: 24449466
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice.
Ostermann L; Maus R; Stolper J; Schütte L; Katsarou K; Tumpara S; Pich A; Mueller C; Janciauskiene S; Welte T; Maus UA
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554955
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
[TBL] [Abstract][Full Text] [Related]
17. α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts.
Nakagiri T; Wrenger S; Sivaraman K; Ius F; Goecke T; Zardo P; Grau V; Welte T; Haverich A; Knöfel AK; Janciauskiene S
Respir Res; 2021 Nov; 22(1):295. PubMed ID: 34789247
[TBL] [Abstract][Full Text] [Related]
18. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β.
Agné A; Richter K; Padberg W; Janciauskiene S; Grau V
Pulm Pharmacol Ther; 2021 Jun; 68():102020. PubMed ID: 33774155
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.
Cosio MG; Bazzan E; Rigobello C; Tinè M; Turato G; Baraldo S; Saetta M
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S305-10. PubMed ID: 27564665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
